![White car (Porsche Taycan) with the hood popped is inside the building with an american flag on the wall.](/sites/default/files/styles/featured_square_large/public/2024-06/2024-P09317.jpg?h=8f9cfe54&itok=m6sQhZRq)
Filter News
Area of Research
- (-) Biology and Environment (4)
- (-) National Security (1)
- (-) Supercomputing (9)
- Advanced Manufacturing (1)
- Clean Energy (17)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (1)
- Isotopes (4)
- Materials (5)
- Materials for Computing (4)
- Neutron Science (7)
- Quantum information Science (3)
- Transportation Systems (1)
News Topics
- (-) Biomedical (5)
- (-) Frontier (3)
- (-) Physics (1)
- (-) Quantum Science (4)
- (-) Transportation (1)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (5)
- Big Data (1)
- Bioenergy (10)
- Biology (19)
- Biotechnology (4)
- Buildings (1)
- Chemical Sciences (2)
- Clean Water (5)
- Climate Change (8)
- Composites (1)
- Computer Science (17)
- Coronavirus (2)
- Cybersecurity (4)
- Decarbonization (1)
- Energy Storage (2)
- Environment (27)
- Exascale Computing (1)
- Fusion (1)
- High-Performance Computing (13)
- Machine Learning (1)
- Materials (3)
- Materials Science (4)
- Mercury (3)
- Microscopy (3)
- Nanotechnology (2)
- National Security (4)
- Neutron Science (3)
- Polymers (1)
- Quantum Computing (5)
- Security (2)
- Summit (6)
- Sustainable Energy (8)
Media Contacts
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![ORNL has modeled the spike protein that binds the novel coronavirus to a human cell for better understanding of the dynamics of COVID-19. Credit: Stephan Irle/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-02/toc_notext_0.png?h=3474dc74&itok=zSrqLz3F)
To better understand the spread of SARS-CoV-2, the virus that causes COVID-19, Oak Ridge National Laboratory researchers have harnessed the power of supercomputers to accurately model the spike protein that binds the novel coronavirus to a human cell receptor.
![The researchers embedded a programmable model into a D-Wave quantum computer chip. Credit: D-Wave](/sites/default/files/styles/list_page_thumbnail/public/2021-02/P5-o5czF_0.jpg?h=b69e0e0e&itok=wCU6WIp_)
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.